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INTRODUCTION
Stasis dermatitis occurs secondary to venous hypertension
of the lower extremities. This disorder has a predilection for
middle-aged to elderly females with venous incompetence or
an inadequate calf pump, and any patients who have deep
vein thromboses. Patients with long-standing venous insuf-
ficiency and lower extremity edema may develop pruritic,
erythematous, scaly papules and plaques on their lower legs,
often in association with brown pigmentation and hair loss.
Dilated or varicose vein is a frequent predisposing factor of
stasis dermatitis. Histopathologic findings include fibrosis,
new blood vessel formations, and hemosiderin deposition in
dermis (1-3).
Cutaneous pigmentation in stasis dermatitis often causes
cosmetic problems for the patients. Hemosiderin and/or
melanin have been considered responsible for the brown pig-
mentation (4, 5). However, there are not sufficient histopatho-
logic studies to explain the pathogenesis of the discoloration
in stasis dermatitis. Melanin is the major determinant of the
normal skin color. Other contributing chromophores are oxy-
hemoglobin (red), deoxygenated hemoglobin (blue), and ca-
rotene (yellow-orange). It is the presence or absence of melanin
in melanosomes that is responsible for the skin color. Melanin
pigment is synthesized in the specialized cytoplasmic orga-
nelles called melanosomes, which contain the principal pig-
ment-synthesizing enzyme, tyrosinase. Melanocytes, special-
ized dendritic cells derived from the neural crest, are the sole
site of melanin formation (6). However, there has been no
report clarifying the role of melanin or melanocytes in the
production of cutaneous pigmentation in stasis dermatitis.
In the present study, we tried to identify the pigments or
cells responsible for the discoloration in stasis dermatitis by
using various special staining techniques for melanin, hemo-
siderin, macrophages, and melanocytes with skin biopsy sam-
ples from 20 patients with stasis dermatitis.
MATERIALS AND METHODS
We selected twenty patients with typical clinical and his-
topathological findings of stasis dermatitis, who visited the
dermatological department of Ajou University Medical Cen-
ter between 1994 and 2001. Clinical analysis and review of
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Role of Dermal Melanocytes in Cutaneous Pigmentation of Stasis
Dermatitis
: A Histopathological Study of 20 Cases
Stasis dermatitis is an itchy, scaly, and hyperpigmented condition of the lower leg
due to venous insufficiency. Hemosiderin and/or melanin have been considered
responsible for the brown pigmentation. However, there are not sufficient histo-
pathologic studies. In this retrospective study the hospital records and biopsy
slides of 20 patients were reviewed to determine the pathogenetic mechanisms
of brown pigmentation in stasis dermatitis. Fifteen were men (75%) and 5 were
women (25%) with a mean age of 46.2±8.2 yr (18-76), mean age at onset of
43.4±18.0 yr (17-73), and a mean duration of the disease 2.8±2.5 yr (0.25-10).
All patients had varicose vein and complained of pruritus. On histopathologic
evaluation, two cases out of 20 (3 skin biopsy specimens from 25 samples) show-
ed dermal melanocytes containing melanin, and incontinence of melanin pigment
was observed in 5 cases, which indicates that melanin pigments from epidermis
could contribute to cutaneous pigmentation in stasis dermatitis. However, the
existence of dermal melanocytes in two cases cannot be explained because nor-
mally the dermis contains no melanocytes. Further studies concerning the role
of iron or inflammatory cytokines on the development of dermal melanocytes
should be conducted. 
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onset, duration of the disease, characteristics of individual
lesions, and other associated dermatologic or systemic dis-
eases.
Light microscopic examinations were undertaken using 25
skin biopsy specimens from 20 patients. Four-micrometer-
thick sections (paraffin blocks) were stained with hematoxylin
and eosin (H&E). However, H&E stain has its limitations in
differentiating melanin from hemosiderin and melanocytes
from siderophages. In order to differentiate melanin from
hemosiderin, we performed Fontana-Masson stains for mela-
nin pigment, Perls’ potassium ferrocyanide stains for Fe3+
(Prussian blue reaction) (7), and potassium ferricyanide stains
for Fe2+ (Turnbull blue reaction) (8). For the differentiation
between melanocytes and macrophages, additional paraffin
sections were obtained and immunohistochemical staining
using antibodies (clone: NKI-beteb) to glycoprotein 100 (GP
100) and antibodies (clone: KP1) to CD68 were performed
(Table 1). The monoclonal anti-melanocyte antibody NKI-
beteb recognizes a 100 kDa (pre) melanosome-associated anti-
gen (glycoprotein) and reacts with melanomas, nevocellular
nevi, and normal melanocytes (9, 10). CD68 is the lysosomal
marker of monocytes/macrophages (11). These procedures were
performed using the standard avidin-biotin peroxidase com-
plex technique. However, each staining method mentioned
above shows only one component (melanin, hemosiderin,
melanocytes, or siderophages) in a section when performed
alone. Therefore, triple stain (immunohistochemical staining
to CD68 combined with Fontana-Masson stain, and Perls’
stain) was performed.
RESULTS
Out of 20 patients, 15 were men (75%) and 5 were women
(25%) with a mean age of 46.2±8.2 yr (18-76). The mean
age at onset of stasis dermatitis was 43.4±18.0 yr, ranging
from 17 to 73. The mean duration of stasis dermatitis was
2.8±2.5 yr (0.25-10) before diagnosis.
Clinical findings
All of the selected patients showed pruritic, erythematous,
scaly papules and plaques with dark-brown to black pigmen-
tation on the lower legs (Fig. 1A). All patients had varicose
vein. Two patients (patient #4, #13) had deep vein throm-
bosis, and one (#1) had long-standing (8 yr) thrombophle-
bitis. One (#8) patient had psoriasis. Hypertension (#3, #6,
#13), angina (#8), old myocardial infarction with mitral valve
stenosis (#13), stroke (#10), liver cirrhosis with esophageal
varix (#3), Behcet’s disease (#4, #12), iatrogenic Cushing
disease (#5), rheumatoid arthritis (#9), acute myelogenous
leukemia (#18), and diabetes (#3, #8) were found in 10 pa-
tients.
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GP 100 NKI-beteb 1:20 Monosan
CD 68 KP1 1:200 Novocastra
Antibodies Clone Dilution Source
Table 1. Immunohistochemical stains
Fig. 1. Patient #9. (A) Scaly, dark brown colored skin eruptions are observed on the left lower leg with varicose vein. (B) Fibrosis and new
blood vessels are seen within upper dermis. Abundant hemosiderin deposits (arrows) showing dark yellow granules are also visible
(H&E,×100).
A BHistopathologic findings
All biopsy specimens showed a combination of the follow-
ing histopathological characteristics (1, 3) of stasis dermati-
tis (Fig. 1B): 1) epidermal changes (hyperkeratosis, paraker-
atosis, and acanthosis), 2) proliferation of superficial dermal
vessels, 3) fibrosis of the reticular dermis, and 4) hemosiderin
depositions in dermis. Five out of 20 patients (#3, #4, #10,
#13, #18) showed incontinence of melanin pigments of a
varying degree (depth=0.12-0.47 mm) in the papillary der-
mis (Fig. 2).
Detection of dermal melanocytes containing melanin
pigments
Two cases out of 20 patients (3 skin biopsy specimens from
25 samples) revealed dermal melanocytes containing melanin
pigments (Fig. 3-5). Skin biopsy samples from patient #1 (M,
25) and #9 (M, 33) showed melanin pigments in Fontana-
Masson stain (Fig 3A, 4A), melanocytes in immunostaining
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Fig. 2. Patient #3. Incontinence of melanin pigments is observed (depth=0.28 mm) (×200). (A) Melanin pigments (arrowheads) in
upper dermis are stained black by Fontana-Masson stain. (B) The melanocytes (MC) in epidermis are stained red by immunohisto-
chemical staining to GP 100, but melanin is not stained (brown). (C) Iron (Fe3+) is stained blue in upper dermis, but melanin (arrow-
heads) is not stained. (D) The cytoplasm of macrophages (M) is stained red by immunohistochemical staining to CD68 (lysosomal






M Mto GP 100 (Fig. 3B, 4B), hemosiderin pigments in Prussian
blue stain (Fig. 3C, 4C) and siderophages in immunostain-
ing to CD68 (Fig. 3D, 4D) in dermis. However, there was
no clinical differences such as skin color, and location of the
lesion between 2 cases showing dermal melanocytes and
others. All patients showed hemosiderin and hemosiderin-
laden macrophages known as siderophages in dermis. Hemo-
siderin pigments were not stained in Turnbull blue reaction
for Fe2+ but were stained blue in Prussian blue reaction for
Fe3+. In addition, triple stain (immunohistochemical stain-
ing to CD68 combined with Fontana-Masson stain, and Perls’
stain) demonstrated the coexistence of melanin, melanocytes,
hemosiderin, and siderophages in one section (Fig. 5).
DISCUSSION
Positive reaction by immunohistochemical staining using
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Fig. 3. Patient #1. Melanocytes are clearly seen in the deep dermis (depth=1.1 mm) in stasis dermatitis (×400). (A) Melanin (arrow-
heads) produced by melanocytes (MC) is stained black by Fontana-Masson stain. (B) The cytoplasm of the melanocyte (MC) is stained
red but partially stained dark by melanin (arrowheads) within the melanocytes by immunohistochemical staining to GP 100. (C) Hemo-
siderin (arrows) within siderophages (S) is stained blue by Perls’ stain for Fe3+ (Prussian blue reaction). Note that brown melanins (arrow-
heads) within the melanocytes (MC) are not stained. (D) The cytoplasm of siderophages (S) is stained red but iron (arrows) is not stained












SNKI-beteb antibodies to GP 100 indicates the presence of
(pre) melanosome in the cytoplasm. The NKI-beteb antibody
is known to be specific to melanoma cells, nevocellular nevi,
and normal melanocytes (9, 10). We employed this immuno-
staining method in pigmented diseases including melasma
(12), nevus of Ota (13), and in image analysis of pigmentary
disorder (14) by using formalin-fixed paraffin embedded
tissue sections. The present study demonstrated the presence
of dermal melanocytes actively synthesizing melanin in two
cases; patients #1 (Fig. 3) and #9 (Fig. 4, 5). These findings
were different from the incontinence of melanin pigment
appeared in 5 cases of this study (patients #3, #4, #10, #13,
#18), where melanin pigments were scattered in the upper
dermis mainly within the melanophages instead of melano-
cytes (Fig. 2). There have been no reports demonstrating the
dermal melanocytes in stasis dermatitis. According to the
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Fig. 4. Patient #9. Melanocytes as well as siderophages are clearly seen in the deep dermis (depth=0.7 mm) of stasis dermatitis (×400).
(A) Melanin (arrowheads) produced by melanocytes (MC) is stained black in Fontana-Masson stain. Note that the golden-yellow col-
ored iron (arrows) is visible within the siderophages (S), but is not stained. (B) The melanocytes (MC) containing melanin (arrowheads)
are stained red by immunohistochemical staining to GP 100. The dark yellow colored iron (arrows) is not stained. (C) Hemosiderin
(arrows) in free form or within siderophages (S) is stained blue by Perls’ stain. Note that wavy melanocytes (MC) containing brown melanin
(arrowheads) are not stained. (D) The cytoplasm of siderophages (S) is stained red by immunohistochemical staining to CD68. Some



















Sreports about postsclerotherapy hyperpigmentation (15, 16),
the skin pigmentation of chronic venous insufficiency is known
to be associated with hemosiderin deposits and/or increased
melanin production. However, none of the patients (n=20)
in this study received previous sclerotherapy before skin biop-
sy at our dermatologic clinic.
Iron and other metal ions including copper and zinc are
known to be the non-melanosome regulatory factors for
melanogenesis (17). Hereditary hemochromatosis, a disease
with a characteristic increase in parenchymal iron, provides
some clues for a certain role of iron in melanogenesis, which
is unclear yet. Milman (18) reported, in a study of 179 pa-
tients with hereditary hemochromatosis, that the skin biop-
sy samples were positive for hemosiderin in 35 (63%) out of
56 patients with skin pigmentation, and positive for melanin
in 26 (58%) out of 45 assessable patients. But there was no
mention about the origin and localization of melanin. There
was no mention about dermal melanocytes, either. Tsuji (19)
injected iron (totaling 7.5 mg per mouse in three doses) into
20 hairless mice intraperitoneally to find out the histological
factor(s) determining clinical pigmentation. He assumed
that the indeterminate dendritic cells in the epidermis would
be activated and would produce melanin, but failed to prove
the production of melanin from epidermis (by the epidermal
dendritic cells) or dermis. As expected, hemosiderin granules
were scattered extracellularly between collagen bundles as
well as within dermal macrophages, Langerhans cells, or in-
determinate dendritic cells of epidermis. The present study
showed incontinence of melanin pigment in 5 cases, which
indicates that melanin pigments from epidermis could con-
tribute to the cutaneous pigmentation in stasis dermatitis
and that iron might have a role in production of melanin.
Melanocytes are normally present in epidermis, not in der-
mis. However, in this study, dermal melanocytes were ob-
served in two patients. In order to understand the pathogen-
esis of “unusual dermal melanocytes” in stasis dermatitis, the
mechanism of other dermatologic diseases such as nevus of
Ota, acquired bilateral nevus of Ota-like macule (ABNOM),
nevus of Ito, Mongolian spots, and dermal melanocytic ha-
martoma (13, 20, 21) should be reviewed. Hori et al. (21)
proposed the following possibilities for the pathogenesis of
ABNOM; 1) the dropping off of epidermal melanocytes, 2)
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Fig. 5. Patient #9. (A) The coexistence of melanin (within melanocytes), iron, and siderophages in the upper and mid dermis is shown on
a single section by triple stain (immunohistochemical staining to CD68 combined with Fontana-Masson stain, and Perls’ stain). (×200).
(B) Iron (arrows) in free form or within siderophages (S) is stained blue. The cytoplasm of siderophages is stained red (×400). (C) Melanin



















Cthe migration of hair bulb melanocytes, 3) the reactivation
of preexisting dermal melanocytes, or 4) triggering of latent
dermal melanocytosis by dermal inflammation. A similar
mechanism is suspected for the development of dermal mela-
nocytes in stasis dermatitis.
Stasis dermatitis develops as a complication of impaired
venous return, and shows the vascular proliferation, red blood
cells extravasation, and hemosiderin deposition histologically.
Inflammatory cytokines or growth factors have been consid-
ered responsible for the pathogenesis of venous leg ulceration
(22, 23). In addition to the mechanism suggested by Hori et
al. (21), we also suggest that iron (hemosiderin), various cyto
kines or growth factors derived from vascular inflammation
might have an unproven effect on possible pluripotent stem
cells which are involved in the development of dermal mela-
nocytes. 
In conclusion, the results of this study propose the possi-
ble role of iron, inflammatory cytokines or growth factors in
the development of dermal melanocytes in stasis dermatitis.
Further studies should be conducted to determine the exact
role of iron and various inflammatory cytokines or growth
factors and to identify the role of pluripotent stem cells in
the pathogenesis of hyperpigmentation in stasis dermatitis.
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